Handl
handl.ai
Actively hiring
Data Collection
Data & Analytics
Artificial Intelligence
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
AI-powered data extraction from documents + human-in-the-loop.
News
Everything You Need to Know About Investing in Strategy Shares Nasdaq 7 Handl ETF
Learn everything you need to know about Strategy Shares Nasdaq 7 Handl ETF (HNDL) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if it's the right fund for you.
Read more
Report
Getting a Handle on the Nasdaq HANDL Methodology
Learn what the Nasdaq HANDL Indexes are, why they were created, and the strategies and methodologies of investing.
Read more
Report
UCB revs up its gene therapy drive with Handl acquisition
UCB has made a new foray into the gene therapy space, buying fellow Belgium-based company Handl to get control of its adeno-associated virus (AAV) capsid delivery platform and two research programmes in neurodegenerative diseases
Read more
Report
Pro access
Upgrade to see all 6 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.